education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Febucid
Febucid
febuxostat
Manufacturer:
Darya-Varia
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Description
Indications/Uses
Dosage/Direction for Use
Contraindications
Special Precautions
Adverse Reactions
Drug Interactions
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Description
Indications/Uses
Dosage/Direction for Use
Contraindications
Special Precautions
Adverse Reactions
Drug Interactions
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Febuxostat
Indications/Uses
Chronic hyperuricemia in conditions where urate deposition has already occurred.
Click to view Febucid detailed prescribing information
Dosage/Direction for Use
80 mg once daily.
Serum uric acid >6 mg/dL (357 μmol/L) after 2-4 wk & risk factor modification failure
120 mg once daily may be considered.
Click to view Febucid detailed prescribing information
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Patients treated w/ azathioprine or mercaptopurine.
Click to view Febucid detailed prescribing information
Special Precautions
Childn <18 yr.
Click to view Febucid detailed prescribing information
Adverse Reactions
Gout flares, liver function abnormalities, diarrhoea, nausea, headache, arthralgia, rash & oedema.
Click to view Febucid detailed prescribing information
Drug Interactions
Concomitant use w/ mercaptopurine, azathioprine, CYP2C8 substrates, theophylline, naproxen or other glucuronidation inhibitors & inducers, colchicine, indomethacin, hydrochlorothiazide, warfarin, desipramine, CYP2D6 substrates.
Click to view Febucid detailed prescribing information
Description
View
Febucid description
for details of the chemical structure and excipients (inactive components).
MIMS Class
Hyperuricemia & Gout Preparations
ATC Classification
M04AA03 - febuxostat ; Belongs to the class of preparations inhibiting uric acid production. Used in the treatment of gout.
Regulatory Classification
K
Presentation/Packing
Form
Febucid FC tab 40 mg
Packing/Price
3 × 10's (Rp120,000/boks)
Form
Febucid FC tab 80 mg
Packing/Price
3 × 10's (Rp240,000/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk Melanjutkan Membaca
Lanjutkan dengan Google
Daftar dengan Email
Sudah menjadi anggota?
Masuk
Daftar Gratis untuk Melanjutkan Membaca
Lanjutkan dengan Google
Daftar dengan Email
Sudah menjadi anggota?
Masuk